I also imagine that commensurate with the gain in revenue for the drugstores, there will probably also be a larger loss in revenue for the oncologists doing the chemo and radiology which will not make them happy, besides the very large loss in revenue for the biopharmas selling the chemo in the treatment of cancer. This could truly be revolutionary for the entire industry and they better be planning for this.